Delivery Order SPE2DB22D9207-SPE2DB25FH5CN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,540.68 to DMS Pharmaceutical Group Inc. for the supply of EYLEA 2 mg/0.05 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, is for pharmaceutical products to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime...
- On August 12, 2025, the Defense Logistics Agency awarded a delivery order valued at $5,943.78 to DMS Pharmaceutical Group Inc. for the supply of EYLEA HD 8 mg/0.07 ml vials. This firm fixed-price delivery order, issued without a set-aside designation, is scheduled for completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and sole awardee on...
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes. The contract, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $39,625.20 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 ml vials on July 16, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. EYLEA HD is a prescription ophthalmic medication used to treat age-related macular degeneration and other retinal conditions, making this a critical...
- The Defense Logistics Agency awarded a $3,770.31 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for EYLEA 2 mg/0.05 mL vials on August 7, 2025, with an ultimate completion date of August 28, 2025. EYLEA is a prescription anti-vascular endothelial growth factor medication used to treat age-related macular degeneration and other retinal conditions. The contract was performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. No set-aside...
- The Defense Logistics Agency (DLA) awarded a $11,887.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The award was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on a competitive basis. DMS Pharmaceutical Group will perform...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Eylea HD 8 mg/0.07 ml vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of August 27, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,962.54 on June 20, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. The award falls under a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the issuance of delivery orders for a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials valued at $198,126.00. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million and valid through November 2026, which enables the...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5CNDelivery Order
The Defense Logistics Agency issued a delivery order valued at $7,925.08 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 ml vials on July 25, 2025, with an ultimate completion date of August 15, 2025. EYLEA is a prescription pharmaceutical product used in the treatment of retinal diseases. This delivery order was issued under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to fulfill this requirement. This delivery order is issued pursuant to DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables DLA to issue task orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription medications, biologics, and medical consumables to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/25/25 |